Skip to main content
LQDA
NASDAQ Life Sciences

Director Sells $720K in Shares Following Option Exercise

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$36.86
Mkt Cap
$3.248B
52W Low
$11.26
52W High
$46.67
52W Position info
227% above low
Off High info
21% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

LQDA has more than doubled off its 52-week low of $11.26.

Summary

A director at Liquidia Corp sold over $720,000 worth of common stock after exercising options, reducing their direct holdings.


Key Events · Ownership and Investor Activity · LQDA

  • Director Sells Shares

    Director Raman Singh sold 20,000 shares of common stock for $720,828 on March 13, 2026.

  • Option Exercise Preceded Sale

    The sale followed the exercise of 20,000 stock options at a price of $4.86 per share, acquired for $97,200.

  • Reduced Direct Holdings

    Post-transaction, the director's direct holdings decreased to 38,755 shares.


Analysis · LQDA · Life Sciences

Director Raman Singh executed an exercise-and-sell transaction, disposing of 20,000 shares for approximately $720,828 after acquiring them through option exercise. While often done for liquidity or tax purposes, this transaction contributes to a broader trend of insider distribution observed over the past 90 days, where net insider sales total over $4.7 million. Investors should note the reduction in direct ownership by a board member.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LQDA was trading at $36.86 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $11.26 to $46.67. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LQDA - Latest Insights

LQDA
Nov 10, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $47.45
Real-time Price: $56.40 info
Change: +$8.95 (+19%) info
Market Cap: $5.119B info
LQDA
Nov 10, 2026, 6:45 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $47.40
Real-time Price: $56.40 info
Change: +$9.00 (+19%) info
Market Cap: $5.119B info
LQDA
Nov 10, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $50.00
Real-time Price: $56.40 info
Change: +$6.40 (+13%) info
Market Cap: $5.119B info
LQDA
Oct 13, 2026, 9:49 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $39.50
Real-time Price: $56.40 info
Change: +$16.90 (+43%) info
Market Cap: $5.119B info
LQDA
Oct 13, 2026, 5:50 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $31.76
Real-time Price: $56.40 info
Change: +$24.64 (+78%) info
Market Cap: $5.119B info